Economic assessments for Chikungunya: a narrative review
DOI:
https://doi.org/10.34119/bjhrv6n4-057Keywords:
economic evaluations, Chikungunya, diagnostic, treatmentAbstract
Chikungunya is an important and growing public health problem that causes high morbidity. Despite the high social and economic impact generated by the disease, few economic evaluations have focused on the disease. The objective of the present study was to perform a narrative review of economic evaluations related to Chikungunya. A review of the scientific literature was performed using the PubMed and Lilacs databases. All identified articles were reviewed by two researchers. The literature search identified 24 articles related to the topic, and after analysis, six studies were included in the present review. These articles were published between 2011 and 2019 and were conducted in the United States, Colombia, France, Mexico and Brazil. All of these studies reported the economic and/or social burden of Chikungunya for patients and/or health services. The main items described in the studies were direct costs related to diagnostic tests, consultations, hospitalizations, medications and rehabilitation, and indirect costs resulting from the loss of patient productivity, years lived with a disability and disability-adjusted life years lost. The results show that economic evaluations related to Chikungunya are recent and limited, and the results are difficult to extrapolate. In this context, more economic studies focusing on Chikungunya are needed.
References
World Health Organization. Chikungunya. https://www.who.int/health-topics/chikungunya#tab=tab_1. Access in on February 10, 2023.
McArthur DB. Emerging Infectious Diseases. Nurs Clin North Am. 2019;54:297–311.
Mourad O, Makhani L, Chen LH. Chikungunya: An Emerging Public Health Concern. Curr Infect Dis. 2022;24:217-28.
de Lima Cavalcanti TYV, Pereira MR, de Paula SO, Franca RF de O. A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development. Viruses. 2022;14:969.
Feldstein LR, Ellis EM, Rowhani-Rahbar A, Hennessey MJ, Staples JE, Halloran ME, et al. Estimating the cost of illness and burden of disease associated with the 2014–2015 chikungunya outbreak in the U.S. Virgin Islands. PLOS Negl Trop Dis. 2019;13:e0007563.
Machado de Assis TS, Rabello A, Cota G. Economic evaluations addressing diagnosis and treatment strategies for neglected tropical diseases: an overview. Rev Inst Med Trop São Paulo. 2021;4;63:e41.
Cardona-Ospina JA, Villamil-Gómez WE, Jimenez-Canizales CE, Castañeda-Hernández DM, Rodríguez-Morales AJ. Estimating the burden of disease and the economic cost attributable to chikungunya, Colombia, 2014. Trans R Soc Trop Med Hyg. 2015;109:793–802.
Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ.1994; 72:429–45.
Alvis-Zakzuk NJ, Díaz-Jiménez D, Castillo-Rodríguez L, Castañeda-Orjuela C, Paternina-Caicedo Á, Pinzón-Redondo H, et al. Economic Costs of Chikungunya Virus in Colombia. Value in Health Reg Issues. 2018;17:32–7.
Soumahoro MK, Boelle PY, Gaüzere BA, Atsou K, Pelat C, Lambert B, et al. The Chikungunya Epidemic on La Réunion Island in 2005–2006: A Cost-of-Illness Study. PLOS Negl Trop Dis. 2011;5:e1197.
Vázquez-Cruz I, Juanico-Morales G, Sánchez-Ramos A, Morales-Sánchez O de J. Costs and sick leave due to chikungunya in the Instituto Mexicano del Seguro Social in Guerrero, Mexico. Rev Med Inst Mex Seguro Soc. 2018;56:54–63.
Teich V, Arinelli R, Fahham L. Aedes aegypti e sociedade: o impacto econômico das arboviroses no Brasil. J Bras Econ Saúde. 2017;9(3):267–76.
Organização Pan-Americana da Saúde. Alerta Epidemiológico: Aumento de casos e óbitos por Chikungunya na Região das Américas. https://www.paho.org/pt/documentos/alerta-epidemiologico-aumento-casos-e-obitos-por-chikungunya-na-regiao-das-americas. Access in on February 10, 2023.
